Healthpeak Properties Business Model Canvas

Partnerships with universities and research institutions align Healthpeak with research anchors to drive concentrated life science demand and clustering near innovation hubs. Ground leases and adjacency to campuses enhance tenant appeal by offering proximity to talent pipelines and shared facilities. Sponsored research ecosystems foster longer lease terms and improve entitlement success while strengthening project branding and market differentiation.

Healthpeak leverages operator partnerships for stable occupancy and NOI improvement, aligns with health systems for anchored medical office cash flow, and partners with life‑science anchors and institutional capital to scale development. Market scale (market cap ~17B in 2024, >20B assets, 350+ properties) underpins joint ventures and long‑term leases.

Negotiate long-term NNN leases with escalators and credit covenants to lock in predictable cash flows for Healthpeak (NYSE: PEAK), targeting lease terms that support portfolio stability and reported 2024 same-store NOI growth of about 2.0%.

Continuously monitor occupancy, rents, and tenant health across life science and medical-office assets, using KPIs to prioritize renewals and mitigate churn.

Execute TI projects and preventive maintenance to preserve asset value and speed lease-up, while optimizing NOI through energy, staffing, and procurement efficiencies.

Source, underwrite and dispose to rotate into life-science, medical-office and senior-housing assets, funding higher-yield deals. Develop/redevelop to deliver modern labs, MOs and CCRCs with a development pipeline >$3.0 billion (2024) and phased pre-leasing. Lock long-term NNN leases and manage debt to support reported 2024 same-store NOI growth ~2.0%.

Longstanding ties with creditworthy healthcare organizations (NYSE:PEAK) give Healthpeak direct insight into pipeline and renewal risk, enabling collaboration on expansions and care delivery trends and reducing downtime and frictional vacancy; portfolio occupancy remained approximately 87% in 2024, supporting stable cash flows and predictable renewal outcomes.

Healthpeak’s clustered portfolio (> $18B, 2024) plus development expertise and national vendor networks drive high-quality, lab-ready and senior assets, supporting ~87% occupancy (2024) and stable AFFO. Investment-grade ratings (S&P BBB, Moody’s Baa2) and a $1.75B revolver preserve liquidity; JV equity expands capacity. Data dashboards and risk models optimize leasing and dispositions.

Locations near hospitals and research anchors maximize network effects; in 2024 Healthpeak concentrated its life science and medical office holdings across 137 cluster assets to deepen ecosystem value. Tenants gain recruitment and collaboration advantages from proximity to clinical trials and academic partners, improving talent access and innovation pipelines. Close location boosts patient and researcher access and supports rent premiums observed in clustered markets.

Purpose-built life-science, medical office and CCR assets deliver compliance-ready, hospital-grade spaces that reduce tenant capex and retrofit timelines, support evolving care models and capture senior-care demand (US 65+ >70M by 2030). NNN leases with escalators, ~96% occupancy and WALT >8 years (2024) produce predictable cash flow. Clustered holdings (137 assets) boost rents and talent access; LEED buildings cut energy ~25% and MEP uptime >99%.

Customized tenant improvements deliver tailored buildouts for labs, imaging, and senior living spaces, aligned with Healthpeak’s 2024 development pipeline of over $1.6 billion. Clear budgeting, timelines, and milestone tracking drive transparency and accountability. Collaborative planning with tenants reduces change orders and accelerates delivery, cutting speed-to-occupancy timelines by focusing on prefab components and fast-track permits.

Long-term leases and C-suite touchpoints for top 20 accounts drive retention across Healthpeak’s $18.6B portfolio (2024), supported by dedicated regional teams, quarterly reviews, and 24–48h escalation SLAs. Data-driven tenant dashboards and a $1.6B 2024 development pipeline cut speed-to-occupancy and improved energy intensity by 6% YoY.

Healthpeak Properties (NYSE:PEAK) as of 2024 focuses on life sciences, medical office and senior housing, leveraging developer and operator networks to source deals. Warm introductions from these partners raise conversion rates and accelerate leasing and dispositions. Transparent pipeline visibility from referrals improves capital planning and allocation. Shared success stories and case studies attract new prospects and partners.

Healthpeak uses direct sales to health systems, broker partnerships for life‑science sourcing, events/site tours for conversion, and digital portals/virtual tours to drive engagement; content marketing generated ~70% of B2B inbound leads in 2024 and virtual tours raised listing engagement ~40%.

Physician groups and ambulatory care (specialty practices, imaging, surgery centers) seek efficient floor plans and ample parking to support high patient throughput and same-day procedures.

They prioritize predictable occupancy costs through long-term, NNN or modified gross leases and budgetable CAM charges to control operating margins.

Healthpeak’s 2024 strategy emphasizes growth via satellite locations near hospitals and population centers to capture outpatient volume and clinician alignment.

Biotech/pharma (2024): concentrated in Boston, SF Bay, San Diego, RTP; need wet/dry labs, scalable MEP and flexible leases.

Health systems: on‑campus/adjacent MOBs, outpatient shift, prefer NNN leases and telehealth/ADA integration.

Physician groups: efficient layouts, parking, predictable occupancy costs; Healthpeak targets hospital-adjacent satellites.

Senior housing: occupancy ~83% (2023); 65+ ≈77M by 2034; JV/phased redevelopments to de-risk.

Development and redevelopment capex covers entitlements, design, and construction expenses, with Healthpeak allocating project budgets that include contingencies—commonly 5–10% for supply‑chain and inflation risk. Interest during build is capitalized per GAAP at prevailing borrowing costs (2024 U.S. policy rates ~5.25–5.50%), materially adding to project cost. Post‑delivery tuning and commissioning budgets (typically 1–3% of hard costs) finalize operational readiness.

Property O&M largely reimbursed under NNN leases in 2024, with owner oversight and vendor contracting key to controlling variable costs. Tenant improvements: lab fit-outs $400–$800 per sq ft; TI allowances $100–$300 per sq ft. Leasing commissions 3–5% of gross rent. Development capex includes 5–10% contingencies; interest during build tied to 2024 U.S. policy rates ~5.25–5.50%.

Healthpeak captures fees from parking, storage, and ancillary services at its life science and medical office campuses, monetizing site amenities to bolster NOI and tenant retention. Ancillary offerings support higher effective rents by enhancing tenancy value and justifying premium lease terms. These streams diversify revenue, smoothing cash flow against lease roll risk.

Base NNN rent provides core recurring income across life-science, medical office and CCRC portfolios, with tenant reimbursements lowering expense volatility and stabilizing NOI. Lease escalators (typically 2–3% fixed or CPI-linked) counter 2024 US inflation of ~3.4%, supporting AFFO visibility. Ancillary fees and milestone-based development/management fees diversify revenue; 2024 dispositions generated ~$1.1B to fund higher-return redeployments.